Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

478 projects found matching your search criteria :

  1. Assessment of long-term effects of semaglutide administered in repeated short cycles in obese mice

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Jakub Łukasz Wojcieszak

    Uniwersytet Medyczny w Łodzi

  2. Synthesis of novel hybrid nanomaterials based on fullerene scaffold for photodynamic therapy of cancer

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Dominik Jakub Dreszer

    UNIWERSYTET ŚLĄSKI

  3. Assessment of the potential of new histidine hybrids and simulation of their metabolism as a potential therapy for neuro...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Paweł Bartosz Szymański

    Uniwersytet Medyczny w Łodzi

  4. Identification and characterization of omics profiles in patients' serum during anti-CD19 CAR-T cell therapy

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Jaromir Bartosz Tomasik

    Warszawski Uniwersytet Medyczny

  5. REMIND HF - Evaluation of REmote Motivational INterviewing for Disease management in Heart Failure patients and their ca...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Izabella Uchmanowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  6. Radiolabelled up-converting nanoparticles as theranostic agents for multimodal imaging and targeted therapy

    Call: SONATINA 8 , Panel: ST5

    Principal investigator: dr Karolina Kinga Zajdel

    Narodowe Centrum Badań Jądrowych

  7. Miniature CRISPR/Cas nucleases for upregulation of utrophin expression: a novel approach for mutation-independent therap...

    Call: DAINA 3 , Panel: NZ3

    Principal investigator: prof. Józef Dulak

    Uniwersytet Jagielloński

  8. Nature-inspired conductive and bioadhesive kirigami-based nanoarchitectured cardiac patch for combined chemo- and stem c...

    Call: OPUS 26 , Panel: ST5

    Principal investigator: dr hab. Filippo Pierini

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  9. Potential pharmacological strategies aimed at alleviating cognitive dysfunctions accompanying oncological therapy while ...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

  10. LighTEM - light-induced in situ electron microscopy and its application in the imaging of light-matter interactions on t...

    Call: SONATA 19 , Panel: ST11

    Principal investigator: dr hab. Andrzej Marek Żak

    Politechnika Wrocławska

  11. Organometallic marriage of sugars with porphyrins. Towards new photosensitizers.

    Call: SONATA 19 , Panel: ST5

    Principal investigator: dr Maciej Malinowski

    Politechnika Warszawska, Wydział Chemiczny

  12. Synthesis, characterization, and evaluation of the biological activity of innovative thermosensitive suppositories compr...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Ewa Olędzka

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  13. First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effect...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński, Collegium Medicum

  14. "One step to game changer": combined antimicrobial therapy based on AI and nanotechnology to combat challenging diabetes...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Barbara Ewa Pucelik

    Sieć Badawcza ŁUKASIEWICZ - Krakowski Instytut Technologiczny

  15. Mitochondrial targets of flozins in endothelial cells - a new approach to the prevention, diagnosis and therapy of heart...

    Call: OPUS 26 , Panel: NZ4

    Principal investigator: dr hab. Barbara Anna Kutryb-Zając

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  16. Modulation of protein interaction networks as a new therapeutic target in the treatment of hereditary retinal dystrophie...

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Xiaonan Liu

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

  17. The sinonasal microbiome - temporal dynamics and alterations caused by selective antibiotic pressure.

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Joanna Agnieszka Szaleniec

    Uniwersytet Jagielloński, Collegium Medicum

  18. Application of superparamagnetic iron oxide nanoparticles (SPION) in inhaled theranostic systems containing antifungal d...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Gabriela Małgorzata Wyszogrodzka-Gaweł

    Uniwersytet Jagielloński, Collegium Medicum

  19. The influence of free and immobilized bacteriophages on a bacterial cellulose-based carrier on human cells and the possi...

    Call: SONATA 19 , Panel: NZ3

    Principal investigator: dr Anna Malwina Żywicka

    Zachodniopomorski Uniwersytet Technologiczny w Szczecinie, Wydział Biotechnologii i Hodowli Zwierząt

  20. Cannabidiol as a modulator of radiological response in the therapy of peripheral nervous system tumors - lipidomics from...

    Call: SONATA 19 , Panel: ST4

    Principal investigator: dr Karolina Anna Chrabąszcz

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

  21. High-throughput agile interfaces for cell sorting

    Call: IMPRESS-U , Panel: NZ3

    Principal investigator: dr Oleksandr Korchynskyy

    Uniwersytet Rzeszowski, Kolegium Nauk Medycznych

  22. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Anna Krętowska-Grunwald

    Uniwersytet Medyczny w Białymstoku

  23. (Micro)RNA and informatics approaches for diagnosis, prognosis and treatment of Alzheimer's disease and Dementia

    Call: JPND Call 2023 , Panel: NZ3

    Principal investigator: dr hab. Agnieszka Fiszer

    Instytut Chemii Bioorganicznej PAN

  24. Unlocking nature's potential - exploring the ability of newly isolated from the environment bacteriophage and its enzyme...

    Call: PRELUDIUM 22 , Panel: NZ9

    Principal investigator: Aleksandra Łukasiak

    Uniwersytet Gdański, Wydział Biologii

  25. Unraveling protease activation in stimulated CAR-T cells to identify new biomarkers for assessing their clinical efficac...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: dr hab. Małgorzata Firczuk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  26. Heterogeneity immunocompetent cells during chimeric antigen receptor T cell (CAR-T) CD19 immunotherapy.

    Call: PRELUDIUM 22 , Panel: NZ6

    Principal investigator: Aleksandra Maria Oszer

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  27. Development of dual immuno-oligo- biosensors for monitoring and controlling of the metastatic colorectal cancer and inve...

    Call: OPUS 25 , Panel: ST4

    Principal investigator: dr hab. Magdalena Stobiecka

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

  28. Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Błażej Rubiś

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  29. Cuproptosis, a novel pathway of regulated cell death as a therapeutic target in treatment-naïve and targeted therapy-res...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: dr hab. Mariusz Łukasz Hartman

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  30. Overcoming CAR-T cell exhaustion via CRISPR- based enhancer modification

    Call: PRELUDIUM 22 , Panel: NZ6

    Principal investigator: dr Karolina Rassek

    Instytut Genetyki Człowieka PAN

  31. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to ...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marika Anna Frańczak

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  32. Investigating the anti-cancerous effect of antioxidant extract from spent coffee grounds on the functioning of normal an...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Adrianna Maria Piasek

    Politechnika Warszawska, Wydział Chemiczny

  33. Efektywność nowatorskiej terapii inhibitorami JAK u pacjentów z reumatoidalnym zapaleniem stawów w odniesieniu do profil...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Sylwia Anna Biały

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  34. Silicon and titanium as beam-activated tumour tracers for online proton therapy monitoring

    Call: PRELUDIUM 22 , Panel: ST2

    Principal investigator: Magdalena Maria Kołodziej

    Uniwersytet Jagielloński, Wydział Fizyki, Astronomii i Informatyki Stosowanej

  35. Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marta Krawczyk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  36. Chimeric Rhodopsin as a novel optogenetic tool

    Call: SONATINA 7 , Panel: NZ5

    Principal investigator: dr Jagoda Płaczkiewicz

    Instytut Chemii Fizycznej Polskiej Akademii Nauk, Międzynarodowe Centrum Badań Oka

  37. Hybrid Nanocomposites Based on Gold Nanoparticles as Promising Photoactive Materials for Combined Photothermal/Photodyna...

    Call: SONATINA 7 , Panel: ST4

    Principal investigator: dr Paulina Błaszkiewicz

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum NanoBioMedyczne

  38. EBI2 receptor as a new myelin repair therapy in multiple sclerosis.

    Call: SONATA 18 , Panel: NZ3

    Principal investigator: dr hab. Aleksandra Rutkowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  39. Potential of TH cell profiling in personalized multiple sclerosis treatmentplanning.

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Donskow-Łysoniewska

    Uczelnia Łazarskiego

  40. Targeted poloxamer micelles with selected drugs as a strategy for overcoming the mechanisms of multidrug resistance in p...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  41. Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr Urszula Helena Piotrowska

    Warszawski Uniwersytet Medyczny

  42. Customized DNA-based nanocarriers to boost heart healing

    Call: M-ERA.NET 2022 , Panel: NZ7

    Principal investigator: dr Monika Bzowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  43. Three-phase drug carriers - design towards a prolonged release, development of a transport model and its verification. C...

    Call: PRELUDIUM BIS 4 , Panel: ST8

    Principal investigator: prof. Anna Trusek

    Politechnika Wrocławska

  44. Investigating the role of fibroblast growth factor receptors and STAT transcription factors in the targeted therapy of a...

    Call: PRELUDIUM BIS 4 , Panel: NZ5

    Principal investigator: prof. Ewa Teresa Marcinkowska

    Uniwersytet Wrocławski, Wydział Biotechnologii

  45. Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

    Call: POLONEZ BIS 3 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  46. Energy storing particles for recharged luminescence bio-tracking and therapy

    Call: OPUS 24 , Panel: ST5

    Principal investigator: dr hab. Dominika Michalina Wawrzyńczyk

    Politechnika Wrocławska

  47. Modifiers of Muscleblind-like genes expression in health and disease.

    Call: SONATA BIS 12 , Panel: NZ5

    Principal investigator: dr hab. Ewa Agnieszka Stępniak-Konieczna

    Uniwersytet Przyrodniczy w Poznaniu, Wydział Rolnictwa, Ogrodnictwa i Biotechnologii

  48. Design and implementation of effective cOmbination of Phages and Antibiotics for improved TheRApy protocols against KLEb...

    Call: JPIAMR ACTION Call 2022 , Panel: NZ6

    Principal investigator: prof. Zuzanna - Drulis-Kawa

    Uniwersytet Wrocławski, Wydział Nauk Biologicznych

  49. Oncogene competition - a new interplay mechanism of mutant p53 with CMYC and mutant KRAS in human cancers.

    Call: OPUS 23 , Panel: NZ5

    Principal investigator: dr hab. Dawid Włodzimierz Walerych

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  50. Bisphosphonate complexes based on103Pd/103mRh in vivo generator for Auger electron therapy of bone cancer metastases

    Call: OPUS 23 , Panel: ST4

    Principal investigator: prof. Aleksander Józef Bilewicz

    Instytut Chemii i Techniki Jądrowej

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy